Skip to content

Thursday, December 3rd, 2009

FDA Advisory: Extreme caution in use of OTC cough and cold medicines

January 18, 2008 by Grace Ibay  
Filed under Diseases & Conditions

The Food and Drug Administration issued a public health advisory strongly recommending that over-the-counter (OTC) cough and cold medicine not be used for infants and children under 2 years of age.

In addition, the American Academy of Pediatrics provided a statement supporting the advisory, and adds

Studies have shown cough and cold products are ineffective in treating symptoms of children under six years old, and may pose serious risks. A variety of rare, serious health problems have been associated with use of these medications in children, including death, convulsions, rapid heart rates and decreased levels of consciousness.

The FDA has recalled several major cough and cold medicines in October for potential misuse. Parents are encouraged to seek safer ways of soothing infants and young children suffering from colds and coughs.

If parents plan on using OTC cough and cold medicines for children 2 years of age and older, the FDA provides further caution at this website.

Tags: , , , , , , , , ,

  • Facebook
  • StumbleUpon
  • Digg
  • Mixx
  • Google
  • TwitThis
  • Reddit
  • Yahoo! Buzz
  • Kirtsy
  • E-mail this story to a friend!

Comments

One Response to “FDA Advisory: Extreme caution in use of OTC cough and cold medicines”
  1. mars2boys says:

    We can never be too cautious when it comes to what we give our kids. So many problems occur when we just don’t read the labels. Never be afraid to call your doctor with questions about meds, or be sure a pharmacist always thoroughly explains your prescription.

    http://www.coldmedicinesandkids.com/

Speak Your Mind

Tell us what you're thinking...
and oh, if you want a pic to show with your comment, go get a gravatar!


About Us | Advertise with us | Blog for Blisstree | Privacy Policy | Terms of Use
Get This Theme | Sitemap


All content is Copyright © 2005-2009 b5media. All rights reserved.